|Articles|October 12, 2012

Trading Away the Medicines of Tomorrow

One of the major issues being negotiated right now the amount of protection for the intellectual property of pharmaceutical and biotech companies. And failure to protect the intellectual property rights will actually hurt patients more than the companies.

Click here to view this article.

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trading Away the Medicines of Tomorrow

Related Content

7 hobbies physicians swear by

Pan-seared miso black cod with fresh fennel, broad beans, and seafood broth

Holiday shopping bonus: 10 more holiday gift ideas for physicians on your ‘nice’ list

Holiday gift ideas for physicians on your ‘nice’ list

3 cornerstones young physicians need for a strong financial foundation

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Medical Economics

New consortium links three medical schools to one community training pipeline

What CMS’ 2027 AI rule means for prior authorization (and maybe for fax machines)

Patients now shop for doctors like consumers, and the bar just got higher

Patients in the wrong Medicare Advantage plan are quietly hurting your practice's revenue

What's really keeping practices independent, with Aaron Ledbetter of Veradigm